FDAnews Drug Daily Bulletin

Pfizer Wins FDA Panel's Backing for Kidney-Cancer Treatment

Dec. 9, 2011
A A
Pfizer Inc., the world's biggest drugmaker, won a U.S. panel's backing for an experimental medicine for advanced kidney cancer in patients who have failed prior treatments.
Businessweek